HotSpot Therapeutics Unveils Promising New IRF5 Inhibitor Data at European Lupus Meeting HotSpot Therapeutics recently shared exciting preclinical data for their new IRF5 inhibitor, showcasing its potential in treating autoimmune diseases at the European Lupus Meeting.

HotSpot Therapeutics Unveils Promising New IRF5 Inhibitor Data at European Lupus Meeting #United_States #Boston #Autoimmune_Diseases #HotSpot_Therapeutics #IRF5_Inhibitor

HotSpot Therapeutics Unveils Cutting-Edge Research at European Lupus Meeting HotSpot Therapeutics is set to showcase groundbreaking preclinical findings on IRF5 inhibitors at the 15th European Lupus Meeting in Lisbon.

HotSpot Therapeutics Unveils Cutting-Edge Research at European Lupus Meeting #Portugal #Lisbon #Lupus_Research #HotSpot_Therapeutics #IRF5_Inhibitor